SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sotac Pharmaceutical - Quaterly Results

13 Aug 2024 Evaluate
The sales slipped to Rs. 130.13 millions, down -31.18% for the June 2024 quarter as against Rs. 189.10 millions during the year-ago period.Profit for the quarter ended June 2024 increased merely by4.15% to Rs. 12.54  millions from Rs. 12.04 millions.Operating profit surged to 25.34 millions from the corresponding previous quarter of 24.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 130.13 189.10 -31.18 130.13 189.10 -31.18 671.05 579.83 15.73
Other Income 4.30 2.32 85.34 4.30 2.32 85.34 13.19 2.43 442.80
PBIDT 25.34 24.90 1.77 25.34 24.90 1.77 115.13 84.52 36.22
Interest 2.57 3.42 -24.85 2.57 3.42 -24.85 10.13 8.61 17.65
PBDT 22.77 21.48 6.01 22.77 21.48 6.01 102.66 75.91 35.24
Depreciation 6.04 4.63 30.45 6.04 4.63 30.45 25.11 16.25 54.52
PBT 16.73 16.85 -0.71 16.73 16.85 -0.71 77.55 59.66 29.99
TAX 4.19 4.81 -12.89 4.19 4.81 -12.89 20.06 14.69 36.56
Deferred Tax -0.16 0.25 -164.00 -0.16 0.25 -164.00 -0.82 -2.15 -61.86
PAT 12.54 12.04 4.15 12.54 12.04 4.15 57.49 44.97 27.84
Equity 110.50 110.50 0.00 110.50 110.50 0.00 110.50 80.50 37.27
PBIDTM(%) 19.47 13.17 47.88 19.47 13.17 47.88 17.16 14.58 17.70
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×